4
Changes in Ownership
Edgewise Therapeutics, Inc. Filed Acc 0001853529-25-000007
Chief Scientific Officer sold 100,000 shares at $21.12 ($2,112,450)
- Chief Scientific Officer acquired 100,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Russell Alan J · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-12 | Exercise or conversion : show line 1 in the form | +100,000 | $0.18 | $18,000 | 123,400 | D |
| 2025-11-12 | Sale : show line 2 in the form | −100,000 | $21.12 | $2,112,450 | 23,400 | D |
| Open-market sales · 100,000 sh · avg $21.12 · $2,112,450 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-11-12 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −100,000 | 1,147,365 | D |
Loading xslF345X05/primarydocument.xml…